|
NASHVILLE, Tenn.--(BUSINESS WIRE)--June 4, 2001--Renal Care Group, Inc. (Nasdaq/NM: RCGI - news) today announced that its chairman and chief executive officer, Sam Brooks, has begun treatment for a tumor in one of his lungs. Mr. Brooks' physicians have prescribed a course of treatment, and he began chemotherapy today. Mr. Brooks' physicians have told him that he should be able to continue his normal activities during his treatment. Renal Care Group's executive vice presidents and other management will continue to operate the business in the normal manner under Mr. Brooks' continuing leadership.
Mr. Brooks said, "When we formed this company five years ago, we adopted a decentralized operating model, and we have successfully implemented that model. I have confidence in our operators and executives to continue to operate the business successfully and to grow. My doctors have told me that I will be able to continue my normal activities, and I plan to do just that."
Renal Care Group indicated that it would refrain from further comment on Mr. Brooks' condition out of respect for Mr. Brooks and his family's right to privacy.
Renal Care Group is a dialysis services company that provides care to patients with kidney disease. The Company currently treats approximately 17,000 patients through 209 owned outpatient dialysis facilities, in addition to providing acute dialysis services to more than 112 hospitals. Over 5,000 associates provide services across the Company's 25-state network.
Certain statements in this press release constitute ''forward-looking statements'' within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect management's expectations and are based upon currently available information. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of Renal Care Group to differ materially from those expressed in or implied by the forward-looking statements, including risks related to: dependence on executive officers; compliance with health care and other applicable laws; the integration of acquired companies; changes in the Medicare and Medicaid programs; risks related to EPO; payment reductions by private insurers, hospitals or managed care organizations; and changes in the health care delivery, financing or reimbursement systems. These and other factors affecting the Company are discussed in more detail in Renal Care Group's reports filed with the Securities and Exchange Commission, including without limitation Renal Care Group's annual report on Form 10-K for the year ended December 31, 2000. Copies of these filings are available from Renal Care Group upon request.
Contact:
Renal Care Group Inc., Nashville
R. Dirk Allison
Chief Financial Officer
615/345-5500
|
Press Releases